Company Valuation: American Oncology Network, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024
Market Cap 1 - - 56.35 137.1
Change - - - 143.33%
Enterprise Value (EV) - - 125.3 215.2
Change - - - 71.77%
P/E - - -4.32x -5.7x
PBR - - -0.35x -3.31x
PEG - - - 0.2x
Capitalization / Revenue - - 0.04x 0.08x
EV / Revenue - - 0x 0x
EV / EBITDA - - -0x -0x
EV / EBIT - - -0x -0x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 - - -1.365 -0.8874
Distribution rate - - - -
Net sales 1 943.7 1,150 1,279 1,759
EBITDA 1 6.99 12.28 -4.668 -5.575
EBIT 1 0.911 5.566 -13.12 -16.09
Net income 1 -0.105 2.589 -5.542 -3.973
Net Debt 36.34 91.97 68.94 78.1
Reference price 2 9.75 10.04 5.90 5.06
Nbr of stocks (in thousands) - - 9,550 27,096
Announcement Date 1/6/23 4/28/23 3/28/24 3/27/25
1USD in Million2USD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 412M
13.99x0.42x8.73x2.8% 121B
13.89x1.77x8.82x0.76% 89.14B
23.23x2.59x13.13x1.4% 26.05B
31.48x5.68x23.32x2.2% 21.29B
8.11x1.44x6.57x-.--% 21.5B
15.28x1.46x7.45x4.46% 14.5B
14.15x1.01x5.67x3.48% 12.53B
12.29x1.57x7.62x0.93% 11.43B
51.2x8.58x32.35x0.2% 10.29B
Average 20.40x 2.72x 12.63x 1.8% 32.86B
Weighted average by Cap. 16.61x 1.73x 10.44x 1.86%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. AONC Stock
  4. Valuation American Oncology Network, Inc.